[1]
Meier, C., Uebelhart, B., Aubry-Rozier, B., Birkhäuser, M., Bischoff-Ferrari, H.A., Frey, D., Kressig, R.W., Lamy, O., Lippuner, K., Stute, P., Suhm, N. and Ferrari, S. 2017. Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). Swiss Medical Weekly. 147, 3334 (Aug. 2017), w14484. DOI:https://doi.org/10.4414/smw.2017.14484.